Physician profile
Prasanth Patcha
NPI 1790090264
$4,550.36
in general payments reported to CMS, 2019-2025
22 companies · $2,112 in 2025
The $2,112 reported for 2025 was more than what 85% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $755 · 2020: $152 · 2021: $197 · 2022: $635 · 2023: $128 · 2024: $571 · 2025: $2,112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,811.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,811.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $955.03 | 2019-2022 | |
| Axogen | $799.57 | 2019-2025 | |
| Smith+Nephew, INC. | $305.36 | 2024-2025 | Stravix, Pico 14, Renasys Touch |
| Rti Surgical, INC | $304.34 | 2022-2024 | |
| Integra Lifesciences Corporation | $289.81 | 2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Avita Medical Americas, LLC | $267.58 | 2025 | Permeaderm, Recell, Cohealyx |
| Mentor Worldwide LLC | $247.39 | 2023-2024 | Artoura Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Polynovo North America LLC | $177.92 | 2025 | Novosorb Btm |
| Motiva USA, LLC | $161.38 | 2025 | |
| Innovation Technologies INC | $157.52 | 2021 | |
| Stryker Corporation | $156.61 | 2025 | Variax |
| Becton, Dickinson and Company | $153.10 | 2025 | Phasix Mesh |
| Acera Surgical, INC. | $132.09 | 2025 | Restrata Wound Matrix |
| Abbvie INC. | $126.84 | 2025 | |
| Baxter Healthcare | $80.86 | 2020-2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $51.15 | 2024 | Retevmo, Jaypirca, Verzenio |
| Osteomed LLC | $44.07 | 2022 | |
| Exsomed Corporation | $39.34 | 2021 | |
| Biocomposites INC | $34.65 | 2025 | Stimulan |
| Kci USA, INC. | $29.65 | 2023 | Activ.A.C. |
| Musculoskeletal Transplant Foundation INC. | $22.42 | 2023 | |
| Tactile Systems Technology INC | $13.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prasanth Patcha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.